Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine dose comparison for cesarean section under general anesthesia
ChiCTR2100042162Phase 4Recruiting
- Sponsor
- Department of Anesthesia and Surgery, Hunan Maternal and Child Health Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine in postoperative pain and None (3 arms), sponsored by Department of Anesthesia and Surgery, Hunan Maternal and Child Health Hospital. Primary endpoints: Apgar scores, Neonatal neurobehavioral score and 2 more. Started Jan 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100042162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042162.